We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+15.27%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$17.3B
AUM Growth
+$1.38B
Cap. Flow
-$440M
Cap. Flow %
-2.54%
Top 10 Hldgs %
32.07%
Holding
728
New
61
Increased
216
Reduced
343
Closed
55

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$85M
2
ABT icon
Abbott
ABT
+$53.8M
3
EXC icon
Exelon
EXC
+$46.6M
4
BSX icon
Boston Scientific
BSX
+$42.6M
5
ABBV icon
AbbVie
ABBV
+$32.4M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$80.5M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$54.5M
3
CRWD icon
CrowdStrike
CRWD
+$45.7M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$40.6M
5
MRK icon
Merck
MRK
+$39.3M

Sector Composition

Rank Sector Weight
1 Technology 36.26%
2 Healthcare 22.78%
3 Financials 10.33%
4 Consumer Discretionary 7.75%
5 Industrials 7.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
276
Bicycle Therapeutics
BCYC
$276M
$8.15M 0.05%
1,172,387
-32,820
-3% -$261K
ED icon
277
Consolidated Edison
ED
$41.1B
$8.14M 0.05%
81,146
+2,074
+3% +$220K
BSY icon
278
Bentley Systems
BSY
$10.2B
$8.11M 0.05%
150,214
-110,340
-42% -$5.11M
KMI icon
279
Kinder Morgan
KMI
$70.6B
$8.06M 0.05%
273,978
-2,579
-0.9% -$70.8K
URI icon
280
United Rentals
URI
$70.2B
$8.05M 0.05%
10,690
-5,683
-35% -$3.8M
ZBRA icon
281
Zebra Technologies
ZBRA
$12.6B
$8.05M 0.05%
26,097
-4,059
-13% -$1.1M
AXSM icon
282
Axsome Therapeutics
AXSM
$12.3B
$8.01M 0.05%
76,727
-3,203
-4% -$339K
CVSA
283
Covista Inc
CVSA
$4.09B
$8.01M 0.05%
62,941
+2,453
+4% +$290K
WMB icon
284
Williams Companies
WMB
$86.6B
$7.97M 0.05%
126,899
-3,299
-3% -$195K
CEG icon
285
Constellation Energy
CEG
$96.4B
$7.95M 0.05%
24,620
+1,852
+8% +$490K
SE icon
286
Sea Limited
SE
$63.9B
$7.86M 0.05%
49,132
-19,215
-28% -$2.78M
IR icon
287
Ingersoll Rand
IR
$33.1B
$7.79M 0.04%
93,598
+12,999
+16% +$1.02M
GAP
288
The Gap Inc
GAP
$7.07B
$7.75M 0.04%
355,381
+337,046
+1,838% +$7.53M
DUOL icon
289
Duolingo
DUOL
$6.19B
$7.7M 0.04%
+18,788
New +$8.24M
TVTX icon
290
Travere Therapeutics
TVTX
$5.27B
$7.59M 0.04%
512,681
-21,391
-4% -$355K
ETNB
291
DELISTED
89bio
ETNB
$7.52M 0.04%
766,211
-65,612
-8% -$543K
EC icon
292
Ecopetrol
EC
$32.5B
$7.44M 0.04%
+841,000
New +$7.44M
IRM icon
293
Iron Mountain
IRM
$37.8B
$7.36M 0.04%
71,723
+1,706
+2% +$161K
MSTR icon
294
Strategy Inc
MSTR
$36B
$7.32M 0.04%
18,118
+4,342
+32% +$1.58M
PTCT icon
295
PTC Therapeutics
PTCT
$6.29B
$7.26M 0.04%
148,595
-10,504
-7% -$499K
ORA icon
296
Ormat Technologies
ORA
$6.28B
$7.25M 0.04%
86,573
-64,272
-43% -$4.81M
COP icon
297
ConocoPhillips
COP
$141B
$7.22M 0.04%
80,489
-7,266
-8% -$654K
AJG icon
298
Arthur J. Gallagher & Co
AJG
$65.1B
$7.14M 0.04%
22,291
+874
+4% +$288K
PDD icon
299
Pinduoduo
PDD
$121B
$7.1M 0.04%
67,800
-113,000
-63% -$11.9M
SLB icon
300
SLB Ltd
SLB
$76.5B
$7.04M 0.04%
208,405
-22,395
-10% -$777K

Similar funds

Candriam SCA's Q2 2025 Portfolio in Review

As of Q2 2025, Candriam SCA held 728 positions worth $17.3B, up 8.6% from $16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q2 2025 filing shows 61 new, 216 increased, 343 reduced and 55 closed positions. Its largest new stake was Tapestry: 260,834 shares worth $22.9M. The largest sale was Tesla, an estimated $80.5M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q2 2025 buy was Tapestry: 260,834 shares worth $22.9M.
  • Candriam SCA added most to Broadcom in Q2 2025, an estimated $85M increase.
  • Candriam SCA's biggest Q2 2025 reduction was Tesla, cutting an estimated $80.5M.
  • Candriam SCA fully exited Banco Macro in Q2 2025, selling an estimated $17.6M.
  • Candriam SCA's ten largest holdings make up 32% of its $17.3B portfolio in Q2 2025.
  • Candriam SCA opened 61 new positions and closed 55 in Q2 2025.
  • Candriam SCA's portfolio value rose 8.6% quarter-over-quarter to $17.3B.

Based on Candriam SCA's 13F filing for Q2 2025, filed 8 Aug 2025.